Susceptibility of anaerobes in phase 3 clinical studies of piperacillin/tazobactam. [electronic resource]
Producer: 19930812Description: S344-8 p. digitalISSN:- 1058-4838
- Bacteria, Anaerobic -- drug effects
- Bacterial Infections -- drug therapy
- Drug Resistance, Microbial
- Drug Therapy, Combination -- administration & dosage
- Humans
- In Vitro Techniques
- Microbial Sensitivity Tests
- Penicillanic Acid -- administration & dosage
- Piperacillin -- administration & dosage
- Tazobactam
- beta-Lactamase Inhibitors
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.